Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Ulvatne

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Dermatology|August 21, 2003
Antimicrobial peptides: potential use in skin infectionsHilde Ulvatne
FEMS Immunology and Medical Microbiology|May 18, 2004
Anti-complement effects of lactoferrin-derived peptidesØrjan Samuelsen, Hanne H Haukland, Hilde Ulvatne, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2002
Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin BHilde Ulvatne, Hanne Husom Haukland, Ørjan Samuelsen, et al.
FEMS Microbiology Letters|August 24, 2004
Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilisHilde Ulvatne, Ørjan Samuelsen, Hanne H Haukland, et al.
FEBS Letters|June 11, 2005
Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureusOrjan Samuelsen, Hanne H Haukland, Håvard Jenssen, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2005
Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin BOrjan Samuelsen, Hanne Husom Haukland, Barbara C Kahl, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Dermatology|August 21, 2003
Antimicrobial peptides: potential use in skin infectionsHilde Ulvatne
FEMS Immunology and Medical Microbiology|May 18, 2004
Anti-complement effects of lactoferrin-derived peptidesØrjan Samuelsen, Hanne H Haukland, Hilde Ulvatne, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2002
Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin BHilde Ulvatne, Hanne Husom Haukland, Ørjan Samuelsen, et al.
FEMS Microbiology Letters|August 24, 2004
Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilisHilde Ulvatne, Ørjan Samuelsen, Hanne H Haukland, et al.
FEBS Letters|June 11, 2005
Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureusOrjan Samuelsen, Hanne H Haukland, Håvard Jenssen, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2005
Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin BOrjan Samuelsen, Hanne Husom Haukland, Barbara C Kahl, et al.
Pageof 1